SEC 13F Intelligence

Rheos Capital Works Inc. / EW

Rheos Capital Works Inc.’s Edwards Lifesciences Corp Position

Does Rheos Capital Works Inc. own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 258.2K shares worth $18M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$18M
Q3 2023
Shares
258.2K
% of Portfolio
+1.08%
Quarters Held
15
position exited

Position History EW

Reported value by quarter
Q1 ’20: $7MQ1 ’20Q2 ’20: $9MQ3 ’20: $11MQ3 ’20Q4 ’20: $12MQ1 ’21: $13MQ1 ’21Q2 ’21: $19MQ3 ’21: $20MQ3 ’21Q4 ’21: $23MQ1 ’22: $21MQ1 ’22Q2 ’22: $17MQ3 ’22: $15MQ3 ’22Q4 ’22: $13MQ1 ’23: $13MQ1 ’23Q2 ’23: $15MQ3 ’23: $18MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023258.2K$18M+1.08%
Q2 2023158.2K$15M+0.80%
Q1 2023158.2K$13M+0.73%
Q4 2022180.2K$13M+0.81%
Q3 2022180.2K$15M+1.00%
Q2 2022180.2K$17M+1.29%
Q1 2022180.2K$21M+1.02%
Q4 2021180.2K$23M+1.02%
Q3 2021180.2K$20M+1.05%
Q2 2021180.2K$19M+0.94%
Q1 2021155.2K$13M+0.86%
Q4 2020135.2K$12M+0.90%
Q3 2020135.2K$11M+0.88%
Q2 2020135.2K$9M+0.65%
Q1 202039.3K$7M+0.79%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rheos Capital Works Inc.’s full portfolio or all institutional holders of EW.